LifeStance Health Group, Inc.: management transactions · United States · SEC (Form 4)

About LifeStance Health Group, Inc.

LifeStance Health Group, Inc. is a U.S.-based outpatient mental health provider listed on the NASDAQ (United States) under the ticker LFST. Founded in 2017, the company was built as a tech-enabled behavioral health platform designed to expand access to care, improve affordability, and deliver more personalized treatment outcomes. Its headquarters are in Scottsdale, Arizona, and its operating footprint is national, with more than 550 centers across 33 states. ([investor.lifestance.com](https://investor.lifestance.com/?utm_source=openai)) LifeStance brings together psychiatrists, psychologists, advanced practice nurses, and therapists to provide integrated mental healthcare for children, adolescents, and adults. Its service offering includes psychotherapy, medication management, testing and evaluation, women’s services, specialty treatments, and care for conditions such as anxiety, depression, and addiction. The company operates through a hybrid model that combines in-person clinics with telehealth capabilities, allowing it to pair clinical proximity with digital convenience. ([lifestance.com](https://lifestance.com/about-us/?utm_source=openai)) From a competitive standpoint, LifeStance ranks among the largest outpatient mental health platforms in the United States, supported by geographic scale, a broad clinician base, and a hybrid care delivery model. According to its 2024 annual report, the company employed 7,424 clinicians across 33 states as of December 31, 2024, and clinicians treated more than 940,000 unique patients over approximately 7.9 million visits during 2024. That scale matters in a highly fragmented market where demand for behavioral health services remains structurally strong. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1845257/000095017025029100/lfst-20241231.htm?utm_source=openai)) Recent developments point to improving operating momentum and a more disciplined capital allocation profile. In its fourth-quarter and full-year 2025 results, LifeStance reported growth in revenue and Adjusted EBITDA, and it guided to 2026 revenue of $1.615 billion to $1.655 billion while also authorizing a share repurchase program of up to $100 million. For investors, that combination suggests a stronger focus on cash generation, margin expansion, and balance sheet efficiency. ([investor.lifestance.com](https://investor.lifestance.com/news-releases/news-release-details/lifestance-reports-fourth-quarter-and-full-year-2025-results/?utm_source=openai)) Strategically, LifeStance’s appeal lies in its large U.S. footprint, exposure to high-prevalence mental health conditions, and ability to deliver care through both physical centers and virtual channels. The company still faces typical sector risks, including reimbursement pressure, clinician recruitment and retention, regulation, cybersecurity, and competition. For French-speaking investors, LFST can be viewed as a growth-oriented healthcare name with a favorable long-term demand backdrop, but one that still depends heavily on execution and operational scalability. ([nasdaq.com](https://www.nasdaq.com/press-release/lifestance-reports-fourth-quarter-and-full-year-2025-results-2026-02-25?utm_source=openai))